Name: 글로벌 시장 동향
SKU: MD1303
Availability: InStock

보고서 요약(국문)

시장 개요
전 세계 망막 임플란트 시장 규모는 2022년 5,978만 달러였으며, 2030년까지 1억 1,817만 달러에 이를 것으로 예상됩니다. 예측 기간(2023~2030년) 동안 연평균 성장률(CAGR)은 9.1%입니다.
망막 보철물 또는 임플란트는 일종의 인공 눈으로, 노인성 황반변성이나 망막색소변성증과 같이 시각 피질이나 시신경이 손상되지 않은 심각한 망막 질환 환자의 시각 감각을 자극하도록 설계된 이식형 전자 장치입니다.
시장 동향
전 세계 망막 임플란트 시장 성장을 견인하는 주요 요인은 적절한 치료가 필요한 안과 질환 발생률 증가로 인한 첨단 기기 수요 증가, 인식 개선 활동 강화, 기술 발전으로 인한 신제품 출시 등입니다.
망막 손상 증가와 고령 인구 증가는 시장 성장을 촉진할 것으로 예상됩니다.

망막 임플란트 시장은 임플란트 수요 증가, 기술 발전, 고령 인구 증가, 연구 개발 투자 증가, 안과 질환 환자 수 증가, 최신 기술을 활용한 신제품 개발, 그리고 신흥 시장의 의료 인프라 개선에 힘입어 성장하고 있습니다.
망막 임플란트는 시각 기능을 자극하는 데 널리 사용됩니다. 이러한 기기의 사용이 증가함에 따라 정부의 지원과 자금 투입도 늘어나고 있습니다. 이러한 자금은 망막색소변성증 치료를 위한 PRIMA, IRIS V2, Argus II와 같은 더욱 발전된 제품 개발에 도움이 될 것입니다. 망막 질환 환자 수 증가로 인해 전 세계적으로 망막 임플란트 시장이 성장하고 있습니다. 또한, 주요 업체들의 기술적으로 진보된 제품 출시 역시 시장 성장에 중요한 역할을 할 것으로 예상됩니다.
다양한 신제품 출시, 연구 활동, 그리고 망막 임플란트 관련 인식 제고 활동 또한 시장 성장에 기여하고 있습니다. 예를 들어, 2022년 1월 31일, 호주의 바이오닉 비전 테크놀로지스(BVT)는 세계 최초의 바이오닉 아이 시스템(Bionic Eye System)이 미국 식품의약국(FDA)으로부터 혁신 의료기기 지정을 받았다고 발표했습니다. 이 획기적인 기술은 유전 질환인 망막색소변성증(RP)으로 시력을 잃은 사람들에게 기능적인 시력을 제공합니다.
망막 질환 치료 비용이 높은 것이 시장 성장을 저해할 것으로 예상됩니다.
하지만 이러한 망막 임플란트와 관련된 불확실한 보험금 지급 정책이 시장 성장을 저해하는 주요 요인입니다. 이러한 불확실성 때문에 의료진과 환자 모두 이러한 기기 도입을 주저하고 있습니다.
망막 질환 치료 비용이 높은 것 또한 망막 임플란트 시장 성장을 저해하는 요인입니다. 아거스 II(Argus II)와 같은 고도화된 임플란트는 약 11만 5천 달러에서 15만 달러에 달합니다. 저소득 또는 중소득 국가에 거주하는 사람들은 이러한 고가의 제품을 구매하기 어렵습니다.

COVID-19 영향 분석
팬데믹은 전 세계 재정 전망, 운영 및 위기 대응 전략에 부정적인 영향을 미쳤습니다. COVID-19 발생은 의료 산업에 심각한 타격을 입혔으며, 망막 임플란트 시장은 COVID-19로 인해 막대한 손실을 경험했습니다. 주요 제조업체들은 다양한 연구 및 임상 시험을 시작했습니다.
전 세계적으로 다양한 계획, 제품 출시, 협력 및 합병이 진행되면서 시장 성장을 촉진하고 있습니다. 망막 관련 안과 질환 및 치료에 대한 대중의 인식이 높아짐에 따라 향후 시장 성장도 가속화될 것입니다.
세그먼트 분석
Argus II 망막 보철 시스템 부문은 예측 기간(2023-2030년) 동안 가장 빠른 연평균 성장률(CAGR)을 기록할 것으로 예상됩니다.
Argus II 망막 보철 시스템 부문은 전 세계 망막 임플란트 시장에서 가장 큰 시장 점유율을 차지하고 있습니다. 전 세계 망막 임플란트 시장은 제품 유형별로 Argus II 망막 보철 시스템, Retina Implant Alpha IMS, 광전식 망막 임플란트(PRIMA), EPI-RET3, 지능형 망막 임플란트 시스템(IRIS V2), 맥락막상 망막 보철, 망막하 망막 보철로 구분됩니다. Argus II 망막 보철 시스템 부문은 전 세계적으로 임플란트 채택이 증가하고 기술 발전과 신제품 출시가 지속됨에 따라 가장 큰 시장 점유율을 차지하고 있습니다.
Argus II는 Second Sight Medical Products에서 개발 및 판매하는 2세대 망막상 미세전극 배열 망막 보철입니다. 미국과 유럽에서 모두 상용화 승인을 받은 최초의 기기입니다. 이 제품의 디자인은 1세대 모델인 Argus I과 비교하여 어레이의 미세 전극 간격 및 개수, 내부 처리 구성 요소의 배치(측두골 함몰부의 피하 배치 대신 공막에 봉합), 그리고 외부 전송 코일의 배치(측두골을 가로질러 내부 구성 요소에 의해 자기적으로 고정되는 대신 안경 측면 프레임에 내장)에서 차이가 있습니다.
규제 승인 증가, 기술 발전, 제품 출시 및 연구/임상 시험 연구가 시장 성장을 견인하고 있습니다. 예를 들어, 시각 장애인을 위한 유용한 시각의 인공 형태를 개발하기 위한 이식형 시각 보철 장치 개발 및 판매업체인 Second Sight Medical Products는 2021년 3월 5일 미국 식품의약국(FDA)으로부터 Argus 2s 망막 보철 시스템에 대한 승인을 받았다고 발표했습니다. Argus II는 망막색소변성증(RP) 치료를 위해 기존에 이식된 Argus II 시스템과 함께 사용하도록 재설계된 외부 하드웨어(비디오 처리 장치)입니다.
지역 분석
북미는 전 세계 망막 임플란트 시장에서 가장 큰 시장 점유율을 차지하고 있습니다.
북미는 인구 규모, 우수한 의료 인프라, 높은 소득 수준을 바탕으로 전 세계 망막 임플란트 시장을 주도하고 있습니다. 미국 내 의료비 지출 증가로 인해 시장은 예측 기간 동안 비교적 완만한 성장세를 보일 것으로 예상됩니다. 시장 규모의 상당 부분은 높은 의료비 지출에 기인합니다.
의료비 지출 증가와 사람들의 인식 제고 또한 이 지역 시장 성장에 기여하고 있습니다. Retina Implant Alpha IMS, Photovoltaic Retinal Implant (PRIMA), EPI-RET3와 같은 망막 임플란트의 발전, 이 지역의 제약 회사 증가, 정부 승인, 그리고 주요 업체들의 존재는 망막 임플란트 시장 성장에 기여하고 있습니다.

또한, 제품 출시 건수 증가가 시장 성장의 주요 요인입니다. 이 지역에서는 많은 핵심 개발, 기술 발전, 협력 및 계약이 활발히 이루어지고 있습니다. 예를 들어, 2021년 9월 6일 바이오닉 비전 테크놀로지스(BVT)는 미국 의료기기 회사인 서텍 메디컬(Cirtec Medical)과 전략적 파트너십을 발표했습니다. 이 파트너십을 통해 서텍은 바이오닉의 전략적 지분을 확보하고 차세대 인공 눈 개발 및 생산을 지원할 예정입니다.
경쟁 환경
망막 임플란트 시장은 국내외 기업들이 경쟁하는 비교적 경쟁적인 시장입니다. 바이오닉 비전 테크놀로지스, 비바니 메디컬(Vivani Medical, Inc.), 삼사라 비전(Samsara Vision Inc.), 비수스 테크놀로지(Visus Technology Inc.), 픽시움 비전(Pixium Vision), 나노 레티나(Nano Retina), 랩티션 안과(Labtician Ophthalmics, Inc.), 비전케어(VisionCare, Inc.), 시코 매니지먼트(Cicor Management AG), 세컨드 사이트 메디컬 프로덕츠(Second Sight Medical Products Inc.) 등이 주요 업체입니다. 이들 업체는 제품 출시, 인수합병, 파트너십, 협력 등 다양한 성장 전략을 통해 시장 성장에 기여하고 있습니다. 예를 들어, 2021년 2월 24일, 인공지능(AI) 기반 FLAIRE 플랫폼 개발사인 Diagnos Inc.는 토론토에 본사를 둔 Labtician Ophthalmics와 전략적 파트너십 계약을 체결했다고 발표했습니다. 이 계약을 통해 Diagnos AI 플랫폼은 안구 건강 모니터링 및 환자 치료 개선을 위해 개발 및 판매될 예정입니다.

Bionic Vision Technologies
개요: Bionic Vision Technologies Pty Ltd는 호주에 본사를 둔 의료기기 회사로, 퇴행성 망막 질환을 가진 사람들의 요구를 충족하는 다양한 최첨단 기술을 개발하여 시력을 보존하고 회복하는 데 주력하고 있습니다. BVT는 Bionic Vision Australia(BVA)에서 개발한 기술을 판매하고 있습니다.

제품 포트폴리오:
Argus II 망막 보철물: 기존에 이식된 Argus II 시스템과 함께 망막색소변성증(RP) 치료에 사용하기 위해 재설계된 외부 하드웨어(비디오 처리 장치)입니다.
글로벌 망막 임플란트 시장 보고서는 약 45개 이상의 시장 데이터 표, 40개 이상의 그림, 그리고 약 200페이지 분량의 자료를 제공합니다.

보고서 요약(영어 원문)

Market Overview
The global retinal implants market size was valued at US$ 59.78 million in 2022 and is estimated to reach US$ 118.17 million by 2030, growing at a CAGR of 9.1% during the forecast period (2023-2030).
Retinal prostheses or implants, a kind of bionic eye, are electronic devices which are implantable and are designed to stimulate vision sensation in the eyes of people with significant retinal disorders such as age-related macular degeneration or retinitis pigmentosa, where the visual cortex or optic nerve are unaffected.
Market Dynamics
The major factors driving the global retinal implants market are the rising demand for advanced devices owing to increasing incidences of ocular disorders requiring proper treatment, surging awareness initiatives, advancements in technologies leading to novel product launches.
The increasing number of retinal damages and rising geriatric populations are expected to drive the market’s growth.
The retinal implants market is driven by increasing demand of implants, rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of ocular diseases and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.
The retinal implants are used widely for stimulating the eye vision sensation. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce more developed products such as PRIMA, IRIS V2 and Argus II for treating retinal pigmentosa. The market for these retinal implants is increasing worldwide due to the enhanced number of people suffering from retinal disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market’s growth.
Various novel product launches, research studies, and rising awareness initiatives related to these Retinal Implants contribute to the market’s growth. For instance, in Jan 31, 2022, Bionic Vision Technologies (BVT) announced about world-first Bionic Eye System of Australia has received breakthrough device designation from the Food and Drug Administration in the United States. This ground-breaking technology provides functional vision to people who due to Retinitis Pigmentosa (RP), the genetic condition, lost their sight.
High cost of treatment associated with retinal disorders are expected to hamper the market’s growth.
However, uncertain reimbursement policies associated with these retinal implants is the key factor which may hamper the market growth. Due to the uncertainty clinicians as well as patients hesitate in adopting these devices.
The high cost of treatments associated with these retinal disorders is also a factor hindering the growth of the retinal implants market. The highly advanced implants such as Argus II cost around $115,000 to $150,000. The people living in low or middle income countries can’t afford such expensive products.
COVID-19 Impact Analysis
The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The retinal implants market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials.
Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market’s growth. The increasing awareness among the population regarding the ocular disorders related to retina and their treatment will also drive the market in upcoming time.
Segment Analysis
The Argus II retinal prosthesis systems segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)
The Argus II Retinal Prosthesis System segment is the highest market holder in the global retinal implants market. The global retinal implants market is segmented based on product type as Argus II Retinal Prosthesis System, Retina Implant Alpha IMS, Photovoltaic Retinal Implant (PRIMA), EPI-RET3, Intelligent Retinal Implant System (IRIS V2), Suprachoroidal Retinal Prosthesis, Subretinal Retinal Prosthesis. The Argus II Retinal Prosthesis Systems segment is the largest market shareholder due to the increasing adoption of these devices globally as implants, increasing technological advancements and novel product launches.
The Argus II is an epiretinal, micro-electrode array retinal prosthesis of second-generation developed and marketed by Second Sight Medical Products. It was approved for commercialization in both the United States and Europe, became the first device to receive that distinction. The design of it differs from the Argus I, the first generation model, in the spacing and number of microelectrodes on the array, the internal processing components placement (instead of subcutaneous placement in the temporal recess it is sutured onto the sclera), and the external transmission coil placement (instead of held magnetically by the internal components across the temporal bone it is built into the sidearm of the glasses).
The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drives the market’s growth. For instance, in March 5, 2021, Second Sight Medical Products, a developer and seller of implantable visual prosthetics intended to develop a useful vision’s artificial form for blind individuals, announced about receiving approval for the Argus 2s Retinal Prosthesis System by the U.S. Food and Drug Administration (FDA). Argus II is a redesigned external hardware (video processing unit) set initially for utilization for the treatment of retinitis pigmentosa (RP) in combination with already implanted Argus II systems.
Geographical Analysis
North America holds the largest market share in the global retinal implants market.
North America dominates the global retinal implants market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market’s significant size is attributed to the high medical expenditure.
Increasing expenditure on healthcare and raising awareness among people is also contributing to the market’s growth in this region. Advancement of retinal implants such as Retina Implant Alpha IMS, Photovoltaic Retinal Implant (PRIMA) and EPI-RET3, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the retinal implants market.
Moreover, the growing number of product launches is responsible for the market’s growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in September 6, 2021, Bionic Vision Technologies (BVT) announced its strategic partnership with Cirtec Medical, a US MedTech company. Under this partnership, Cirtec received a strategic stake in Bionic and will further assist them in developing and producing its next-generation bionic eye.
Competitive Landscape
The retinal implants market is moderately competitive with local and global companies’ presence. Bionic Vision Technologies, Vivani Medical, Inc., Samsara Vision Inc., Visus Technology Inc., Pixium Vision, Nano Retina, Labtician Ophthalmics, Inc., VisionCare, Inc., Cicor Management AG, Second Sight Medical Products Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market’s growth. For instance, in February 24, 2021, Diagnos Inc., a FLAIRE platform based on Artificial Intelligence (AI) developer, announced its strategic agreement of partnership with Labtician Ophthalmics, a Toronto-based company introducing and marketing DIAGNOS AI platform for ocular health monitoring and improve patient care.
Bionic Vision Technologies
Overview: Bionic Vision Technologies Pty Ltd is a medical device company based in Australia that is focused in preserving and restoring a sense of vision by creating a range of best technologies for meeting the needs of people having degenerative retinal conditions. BVT is marketing the technologies developed by Bionic Vision Australia (BVA).
Product Portfolio:
Argus II Retinal Prosthesis: It is a redesigned external hardware (video processing unit) set initially for utilization for the treatment of retinitis pigmentosa (RP) in combination with already implanted Argus II systems
The global retinal implants market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Market Definition and Overview
3. Executive Summary
4. Market Dynamics
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing Number Of Retinal Damages
4.1.1.2. Rising Geriatric Population
4.1.2. Restraints:
4.1.2.1. High Cost Of Treatments
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1 Porter's Five Forces Analysis
5.2 Supply Chain Analysis
5.3 Pricing Analysis
6. COVID-19 Analysis
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturer’s Strategic Initiatives
6.6. Conclusion
7. By Product Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
7.1.2. Market Attractiveness Index, By Product Type
7.2. Argus II Retinal Prosthesis System*
7.2.1. Introduction
7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
7.3. Retina Implant Alpha IMS
7.4. Photovoltaic Retinal Implant (PRIMA)
7.5. EPI-RET3
7.6. Intelligent Retinal Implant System (IRIS V2)
7.7. Suprachoroidal Retinal Prosthesis
7.8. Subretinal Retinal Prosthesis
8. By Implants Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
8.1.2. Market Attractiveness Index, By Implants Type
8.2. Epiretinal *
8.2.1. Introduction
8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
8.3. Subretinal
8.4. Suprachoroidal
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Retinitis Pigmentosa *
9.2.1. Introduction
9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
9.3. Age-Related Macular Degeneration
9.4. Diabetic Eye Disease
9.5. Retinal Detachment
10. By End User
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
10.1.2. Market Attractiveness Index, By End User
10.2. Hospitals *
10.2.1. Introduction
10.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
10.3. Ambulatory Surgical Centers
10.4. Eye-care Centers
11. By Region
11.1. Introduction
11.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
11.1.2. Market Attractiveness Index, By Region
11.2. North America
11.2.1. Introduction
11.2.2. Key Region-Specific Dynamics
11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.2.7.1. U.S.
11.2.7.2. Canada
11.2.7.3. Mexico
11.3. Europe
11.3.1. Introduction
11.3.2. Key Region-Specific Dynamics
11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.3.7.1. Germany
11.3.7.2. U.K.
11.3.7.3. France
11.3.7.4. Italy
11.3.7.5. Spain
11.3.7.6. Rest of Europe
11.4. South America
11.4.1. Introduction
11.4.2. Key Region-Specific Dynamics
11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.4.7.1. Brazil
11.4.7.2. Argentina
11.4.7.3. Rest of South America
11.5. Asia Pacific
11.5.1. Introduction
11.5.2. Key Region-Specific Dynamics
11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
11.5.7.1. China
11.5.7.2. India
11.5.7.3. Japan
11.5.7.4. Australia
11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
11.6.1. Introduction
11.6.2. Key Region-Specific Dynamics
11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Implants Type
11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
12. Competitive Landscape
12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Products Benchmarking
12.4. List of Key Companies to Watch
13. Company Profiles
13.1. Bionic Vision Technologies *
13.1.1. Company Overview
13.1.2. Product Portfolio and Description
13.1.3. Key Highlights
13.1.4. Financial Overview
13.2. Vivani Medical, Inc.
13.3. Samsara Vision Inc.
13.4. Visus Technology Inc.
13.5. Pixium Vision
13.6. Nano Retina
13.7. Labtician Ophthalmics, Inc.
13.8. VisionCare, Inc.
13.9. Cicor Management AG
13.10. Second Sight Medical Products Inc.
LIST NOT EXHAUSTIVE
14. Global Retinal Implants Market – DataM
14.1. Appendix
14.2. About Us and Medications
14.3. Contact Us

언급된 주요 기업들

Bionic Vision Technologies, Vivani Medical, Inc., Samsara Vision Inc., Visus Technology Inc., Pixium Vision, Nano Retina, Labtician Ophthalmics, Inc., VisionCare, Inc., Cicor Management AG, Second Sight Medical Products Inc.

표 목록 (Tables)

List of Tables

Table 1 Global Retinal Implants Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Global Retinal Implants Market Value, By Implants Type, 2023, 2027 & 2031 (US$ Million)

Table 3 Global Retinal Implants Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 4 Global Retinal Implants Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 5 Global Retinal Implants Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 6 Global Retinal Implants Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 7 Global Retinal Implants Market Value, By Product Type, 2022-2031 (US$ Million)

Table 8 Global Retinal Implants Market Value, By Implants Type, 2023, 2027 & 2031 (US$ Million)

Table 9 Global Retinal Implants Market Value, By Implants Type, 2022-2031 (US$ Million)

Table 10 Global Retinal Implants Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 11 Global Retinal Implants Market Value, By Application, 2022-2031 (US$ Million)

Table 12 Global Retinal Implants Market Value, By End User, 2023, 2027 & 2031 (US$ Million)

Table 13 Global Retinal Implants Market Value, By End User, 2022-2031 (US$ Million)

Table 14 Global Retinal Implants Market Value, By Region, 2023, 2027 & 2031 (US$ Million)

Table 15 Global Retinal Implants Market Value, By Region, 2022-2031 (US$ Million)

Table 16 North America Retinal Implants Market Value, By Product Type, 2022-2031 (US$ Million)

Table 17 North America Retinal Implants Market Value, By Implants Type, 2022-2031 (US$ Million)

Table 18 North America Retinal Implants Market Value, By Application, 2022-2031 (US$ Million)

Table 19 North America Retinal Implants Market Value, By End User, 2022-2031 (US$ Million)

Table 20 North America Retinal Implants Market Value, By Country, 2022-2031 (US$ Million)

Table 21 South America Retinal Implants Market Value, By Product Type, 2022-2031 (US$ Million)

Table 22 South America Retinal Implants Market Value, By Implants Type, 2022-2031 (US$ Million)

Table 23 South America Retinal Implants Market Value, By Application, 2022-2031 (US$ Million)

Table 24 South America Retinal Implants Market Value, By End User, 2022-2031 (US$ Million)

Table 25 South America Retinal Implants Market Value, By Country, 2022-2031 (US$ Million)

Table 26 Europe Retinal Implants Market Value, By Product Type, 2022-2031 (US$ Million)

Table 27 Europe Retinal Implants Market Value, By Implants Type, 2022-2031 (US$ Million)

Table 28 Europe Retinal Implants Market Value, By Application, 2022-2031 (US$ Million)

Table 29 Europe Retinal Implants Market Value, By End User, 2022-2031 (US$ Million)

Table 30 Europe Retinal Implants Market Value, By Country, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Retinal Implants Market Value, By Product Type, 2022-2031 (US$ Million)

Table 32 Asia-Pacific Retinal Implants Market Value, By Implants Type, 2022-2031 (US$ Million)

Table 33 Asia-Pacific Retinal Implants Market Value, By Application, 2022-2031 (US$ Million)

Table 34 Asia-Pacific Retinal Implants Market Value, By End User, 2022-2031 (US$ Million)

Table 35 Asia-Pacific Retinal Implants Market Value, By Country, 2022-2031 (US$ Million)

Table 36 Middle East & Africa Retinal Implants Market Value, By Product Type, 2022-2031 (US$ Million)

Table 37 Middle East & Africa Retinal Implants Market Value, By Implants Type, 2022-2031 (US$ Million)

Table 38 Middle East & Africa Retinal Implants Market Value, By Application, 2022-2031 (US$ Million)

Table 39 Middle East & Africa Retinal Implants Market Value, By End User, 2022-2031 (US$ Million)

Table 40 Bionic Vision Technologies: Overview

Table 41 Bionic Vision Technologies: Product Portfolio

Table 42 Bionic Vision Technologies: Key Developments

Table 43 Vivani Medical, Inc.: Overview

Table 44 Vivani Medical, Inc.: Product Portfolio

Table 45 Vivani Medical, Inc.: Key Developments

Table 46 Samsara Vision Inc.: Overview

Table 47 Samsara Vision Inc.: Product Portfolio

Table 48 Samsara Vision Inc.: Key Developments

Table 49 Visus Technology Inc.: Overview

Table 50 Visus Technology Inc.: Product Portfolio

Table 51 Visus Technology Inc.: Key Developments

Table 52 Pixium Vision: Overview

Table 53 Pixium Vision: Product Portfolio

Table 54 Pixium Vision: Key Developments

Table 55 Nano Retina: Overview

Table 56 Nano Retina: Product Portfolio

Table 57 Nano Retina: Key Developments

Table 58 Labtician Ophthalmics, Inc.: Overview

Table 59 Labtician Ophthalmics, Inc.: Product Portfolio

Table 60 Labtician Ophthalmics, Inc.: Key Developments

Table 61 VisionCare, Inc.: Overview

Table 62 VisionCare, Inc.: Product Portfolio

Table 63 VisionCare, Inc.: Key Developments

Table 64 Cicor Management AG: Overview

Table 65 Cicor Management AG: Product Portfolio

Table 66 Cicor Management AG: Key Developments

Table 67 Second Sight Medical Products Inc.: Overview

Table 68 Second Sight Medical Products Inc.: Product Portfolio

Table 69 Second Sight Medical Products Inc.: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 2 Global Retinal Implants Market Share, By Product Type, 2022 & 2031 (%)

Figure 3 Global Retinal Implants Market Share, By Implants Type, 2022 & 2031 (%)

Figure 4 Global Retinal Implants Market Share, By Application, 2022 & 2031 (%)

Figure 5 Global Retinal Implants Market Share, By End User, 2022 & 2031 (%)

Figure 6 Global Retinal Implants Market Share, By Region, 2022 & 2031 (%)

Figure 7 Global Retinal Implants Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 8 Argus II Retinal Prosthesis System: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 9 Retina Implant Alpha IMS: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 10 Photovoltaic Retinal Implant (PRIMA): Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 11 EPI-RET3: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 12 Intelligent Retinal Implant System (IRIS V2): Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 13 Suprachoroidal Retinal Prosthesis: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 14 Subretinal Retinal Prosthesis: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 15 Global Retinal Implants Market Y-o-Y Growth, By Implants Type, 2022-2031 (%)

Figure 16 Epiretinal: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 17 Subretinal: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 18 Suprachoroidal: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 19 Global Retinal Implants Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 20 Retinitis Pigmentosa: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 21 Age-Related Macular Degeneration: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 22 Diabetic Eye Disease: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 23 Retinal Detachment: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 24 Global Retinal Implants Market Y-o-Y Growth, By End User, 2022-2031 (%)

Figure 25 Hospitals: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 26 Ambulatory Surgical Centers: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 27 Eye-care Centers: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 28 Global Retinal Implants Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 29 North America: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 30 Asia-Pacific: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 31 Europe: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 32 South America: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 33 Middle East and Africa: Global Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 34 North America Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 35 North America Retinal Implants Market Share, By Product Type, 2022 & 2031 (%)

Figure 36 North America Retinal Implants Market Share, By Implants Type, 2022 & 2031 (%)

Figure 37 North America Retinal Implants Market Share, By Application, 2022 & 2031 (%)

Figure 38 North America Retinal Implants Market Share, By End User, 2022 & 2031 (%)

Figure 39 North America Retinal Implants Market Share, By Country, 2022 & 2031 (%)

Figure 40 South America Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 41 South America Retinal Implants Market Share, By Product Type, 2022 & 2031 (%)

Figure 42 South America Retinal Implants Market Share, By Implants Type, 2022 & 2031 (%)

Figure 43 South America Retinal Implants Market Share, By Application, 2022 & 2031 (%)

Figure 44 South America Retinal Implants Market Share, By End User, 2022 & 2031 (%)

Figure 45 South America Retinal Implants Market Share, By Country, 2022 & 2031 (%)

Figure 46 Europe Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 47 Europe Retinal Implants Market Share, By Product Type, 2022 & 2031 (%)

Figure 48 Europe Retinal Implants Market Share, By Implants Type, 2022 & 2031 (%)

Figure 49 Europe Retinal Implants Market Share, By Application, 2022 & 2031 (%)

Figure 50 Europe Retinal Implants Market Share, By End User, 2022 & 2031 (%)

Figure 51 Europe Retinal Implants Market Share, By Country, 2022 & 2031 (%)

Figure 52 Asia-Pacific Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 53 Asia-Pacific Retinal Implants Market Share, By Product Type, 2022 & 2031 (%)

Figure 54 Asia-Pacific Retinal Implants Market Share, By Implants Type, 2022 & 2031 (%)

Figure 55 Asia-Pacific Retinal Implants Market Share, By Application, 2022 & 2031 (%)

Figure 56 Asia-Pacific Retinal Implants Market Share, By End User, 2022 & 2031 (%)

Figure 57 Asia-Pacific Retinal Implants Market Share, By Country, 2022 & 2031 (%)

Figure 58 Middle East & Africa Retinal Implants Market Value, 2022-2031 (US$ Million)

Figure 59 Middle East & Africa Retinal Implants Market Share, By Product Type, 2022 & 2031 (%)

Figure 60 Middle East & Africa Retinal Implants Market Share, By Implants Type, 2022 & 2031 (%)

Figure 61 Middle East & Africa Retinal Implants Market Share, By Application, 2022 & 2031 (%)

Figure 62 Middle East & Africa Retinal Implants Market Share, By End User, 2022 & 2031 (%)

Figure 63 Bionic Vision Technologies: Financials

Figure 64 Vivani Medical, Inc.: Financials

Figure 65 Samsara Vision Inc.: Financials

Figure 66 Visus Technology Inc.: Financials

Figure 67 Pixium Vision: Financials

Figure 68 Nano Retina: Financials

Figure 69 Labtician Ophthalmics, Inc.: Financials

Figure 70 VisionCare, Inc.: Financials

Figure 71 Cicor Management AG: Financials

Figure 72 Second Sight Medical Products Inc.: Financials

세계 망막 임플란트 시장 – 2023-2030

Global Retinal Implants Market - 2023-2030